Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Scripts who wrote (1213)	6/26/2001 4:22:31 PM
From: Ian@SI	Read Replies (2) \| Respond to of 1321

I think it was Merrill Lynch Canada that cut the target to $40Cdn yesterday... The analysts just seem to be acknowledging that the current price is much lower than their targets. i.e. Why get 1 brownie point when you can play the same move and get 2 brownie points or more? <g> Ian. _+++++++++++ 06/25 09:57 QLT Inc. Estimate Cut at Merrill Lynch QLT Inc. (QLTI US) was maintained near-term ``accumulate'' by analyst Hari Sambasivam at Merrill Lynch. The 12-18 month price target was cut to C$40 from C$60 per share. 06/14 13:54 QLT Inc. Price Target Cut at HCFP/Brenner QLT Inc. (QLTI US) was reiterated ``strong buy'' by analyst Samuel Gerszonowicz at HCFP/Brenner Securities. The 12-to-18-month target price was cut to $39.00 per share from $51.00 per share.